Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more.

Chiossone L, Vienne M, Kerdiles YM, Vivier E.

Semin Immunol. 2017 Jun;31:55-63. doi: 10.1016/j.smim.2017.08.003. Epub 2017 Sep 22. Review.

PMID:
28943093
2.

Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells.

Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, Huntington ND, Raulet DH, Nutt SL, Belz GT, Vivier E.

Immunity. 2017 Aug 15;47(2):199-200. doi: 10.1016/j.immuni.2017.07.026. No abstract available.

3.

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E.

Sci Immunol. 2017 Apr 28;2(10). pii: eaam9628. doi: 10.1126/sciimmunol.aam9628.

4.

ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation.

Stone EL, Pepper M, Katayama CD, Kerdiles YM, Lai CY, Emslie E, Lin YC, Yang E, Goldrath AW, Li MO, Cantrell DA, Hedrick SM.

Immunity. 2015 Feb 17;42(2):239-251. doi: 10.1016/j.immuni.2015.01.017.

5.

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.

Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18324-9. doi: 10.1073/pnas.1112064108. Epub 2011 Oct 21.

6.

The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells.

Narni-Mancinelli E, Vivier E, Kerdiles YM.

Int Immunol. 2011 Jul;23(7):427-31. doi: 10.1093/intimm/dxr035. Epub 2011 Jun 10.

PMID:
21665959
7.

Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance.

Guia S, Jaeger BN, Piatek S, Mailfert S, Trombik T, Fenis A, Chevrier N, Walzer T, Kerdiles YM, Marguet D, Vivier E, Ugolini S.

Sci Signal. 2011 Apr 5;4(167):ra21. doi: 10.1126/scisignal.2001608.

8.

Foxo transcription factors control regulatory T cell development and function.

Kerdiles YM, Stone EL, Beisner DR, McGargill MA, Ch'en IL, Stockmann C, Katayama CD, Hedrick SM.

Immunity. 2010 Dec 14;33(6):890-904. doi: 10.1016/j.immuni.2010.12.002. Erratum in: Immunity. 2011 Jan 28;34(1):135. Beisner, Daniel L [corrected to Beisner, Daniel R].

9.

Highly specialized role of Forkhead box O transcription factors in the immune system.

Dejean AS, Hedrick SM, Kerdiles YM.

Antioxid Redox Signal. 2011 Feb 15;14(4):663-74. doi: 10.1089/ars.2010.3414. Epub 2010 Dec 13. Review.

10.

The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice.

Weidemann A, Kerdiles YM, Knaup KX, Rafie CA, Boutin AT, Stockmann C, Takeda N, Scadeng M, Shih AY, Haase VH, Simon MC, Kleinfeld D, Johnson RS.

J Clin Invest. 2009 Nov;119(11):3373-83. doi: 10.1172/JCI39378. Epub 2009 Oct 5.

11.

Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.

Dejean AS, Beisner DR, Ch'en IL, Kerdiles YM, Babour A, Arden KC, Castrillon DH, DePinho RA, Hedrick SM.

Nat Immunol. 2009 May;10(5):504-13. doi: 10.1038/ni.1729. Epub 2009 Apr 12.

12.

Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM.

Nat Immunol. 2009 Feb;10(2):176-84. doi: 10.1038/ni.1689. Epub 2009 Jan 11.

13.

Immunomodulatory properties of morbillivirus nucleoproteins.

Kerdiles YM, Cherif B, Marie JC, Tremillon N, Blanquier B, Libeau G, Diallo A, Wild TF, Villiers MB, Horvat B.

Viral Immunol. 2006 Summer;19(2):324-34.

PMID:
16817775
14.

Immunosuppression caused by measles virus: role of viral proteins.

Kerdiles YM, Sellin CI, Druelle J, Horvat B.

Rev Med Virol. 2006 Jan-Feb;16(1):49-63. Review.

PMID:
16237742

Supplemental Content

Loading ...
Support Center